Epstein-Barr Virus MicroRNAs as Key Regulators of Lymphoma Pathogenesis: Immune Evasion Mechanisms and Therapeutic Opportunities.
Viral micro-RNAs drive immune escape in EBV-positive lymphomas, offering actionable targets for new cancer treatments in hematologic malignancies.
EBV miRNAs are central mediators of immune evasion in EBV-positive lymphomas, with actionable therapeutic implications for targeting viral miRNAs in hematologic malignancies. The review consolidates rapidly evolving knowledge of viral miRNA mechanisms in lymphomagenesis.
What the study was
- Study design
- Narrative review
- Population
- EBV-positive lymphoma patients (review context)
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- European journal of haematology
Why it surfaced
EBV miRNA therapeutic targeting in lymphoma; narrative review; relevant for EBV+ lymphoma research.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.